UAE Next Generation Sequencing Market Report 2018-2028, By Region, By Competition Forecast & Key Opportunities


Dublin, Feb. 22, 2024 (GLOBE NEWSWIRE) -- The "UAE Next Generation Sequencing Market, By Region, By Competition Forecast & Opportunities, 2018-2028F" report has been added to ResearchAndMarkets.com's offering.

The United Arab Emirates (UAE) is witnessing an impressive growth trajectory within the Next Generation Sequencing (NGS) market, as per the latest comprehensive industry research spanning the forecast period from 2018 to 2028.

NGS technology, known for its high-throughput sequencing capabilities, is increasingly becoming a cornerstone technology in the field of genomics with applications stretching across clinical diagnostics, cancer research, and precision medicine strategies. This growth is underpinned by the rising incidence of genetic disorders, significant advancements in NGS technologies, and the surging demand for prenatal and newborn screening programs in the region.

Technological Advances Spearhead Market Expansion

The market is being driven predominantly by continuous technological innovations, such as Ion Semiconductor Sequencing, which has garnered a substantial share of the UAE market. Improved accuracy, higher throughput, and cost reductions are hallmarks of these advancements that are expanding both the accessibility and application range of NGS.

This technology is particularly noted for its targeted sequencing capabilities, playing a vital role in personalized treatment plans and contributing to the rapid turnaround times demanded in today's clinical settings.

Rise in Genetic Disorders Influences NGS Adoption

A significant factor propelling the NGS market forward within the UAE is the increasing prevalence of genetic disorders. NGS offers a comprehensive genomic analysis, enabling healthcare professionals to identify a myriad of genetic variations that could be linked to disease. This technology has transformed prenatal, neonatal, and adult genetic screening, enhancing the ability to personalize medical treatments considerably.

Adoption of NGS in Biomarker Discovery and Cancer Genomics

In the application segment, biomarkers and cancer emerge as areas of extensive growth. The NGS technology enables the profiling of cancerous genomes and the discovery of precise biomarkers for disease monitoring and therapy guidance. As a result, the segment demonstrates a robust potential for the development of novel cancer diagnostics and therapeutic strategies.

Pharmaceutical Sector Leads End-User Segment

Pharmaceutical and biotechnological companies are significant end-users in the NGS market, utilizing this technology for drug development, patient stratification in clinical trials, and the creation of companion diagnostics. The deployment of NGS by these companies is instrumental in streamlining the drug discovery process, tailoring pharmaceutical development, and enabling the rise of precision medicine.

Regional Insights Spotlight Abu Dhabi as a Market Leader

Abu Dhabi is at the forefront of the NGS market within the UAE, attributed to its robust investment in healthcare infrastructure and genomics research initiatives. The strategic focus on integrating NGS into clinical practice has established the region as a significant contributor to the nationwide growth of this market.

Next Generation Sequencing Market, By Product:

  1. Consumables
  2. Platforms
  3. Services

Next Generation Sequencing Market, By Technology:

  1. Sequencing by Synthesis
  2. Ion Semiconductor Sequencing
  3. Others

Next Generation Sequencing Market, By Application:

  1. Biomarkers & Cancer
  2. Diagnostics
  3. Others

Next Generation Sequencing Market, By End-User:

  1. Academic & Clinical Research Centers
  2. Pharmaceutical & Biotechnology Companies
  3. Others

Next Generation Sequencing Market, By Region:

  1. Dubai
  2. Abu Dhabi
  3. Others

This extensive research endeavors to provide detailed insights into the development and future prospects of the NGS market across the UAE. For stakeholders, healthcare providers, and industry leaders, these insights are an invaluable asset for planning and strategic decision-making in the ever-evolving landscape of genomics and precision medicine.

For more information about this report visit https://www.researchandmarkets.com/r/gw7dru

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

 

Kontaktdaten